Skip to main content

and
  1. Article

    Open Access

    Accuracy, Acceptability, and Application: Fecal Immunochemical Tests for Early Detection of Advanced Neoplasia in Colonoscopy-Based Surveillance

    The fecal immunochemical test (FIT) is widely used in colorectal cancer (CRC) screening, but limited data exist for its application in individuals at above-average risk for CRC who complete surveillance colono...

    Molla M. Wassie, Maddison Dix, Geraldine Laven-Law in Digestive Diseases and Sciences (2024)

  2. Article

    Open Access

    Selective inhibition of CDK9 in triple negative breast cancer

    Targeted therapy for triple-negative breast cancers (TNBC) remains a clinical challenge due to tumour heterogeneity. Since TNBC have key features of transcriptionally addicted cancers, targeting transcription ...

    Ebtihal H. Mustafa, Geraldine Laven-Law, Zoya Kikhtyak, Van Nguyen, Simak Ali in Oncogene (2024)

  3. Article

    Open Access

    FIT for purpose: study protocol for a randomized controlled trial to personalize surveillance colonoscopy for individuals at elevated risk of colorectal cancer

    There is increasing demand for colorectal cancer (CRC) surveillance, but healthcare capacity is limited. The burden on colonoscopy resources could be reduced by personalizing surveillance frequency using the f...

    Jean M. Winter, Kathryn J. Cornthwaite in International Journal of Colorectal Disease (2023)

  4. Article

    Open Access

    Modifier locus map** of a transgenic F2 mouse population identifies CCDC115 as a novel aggressive prostate cancer modifier gene in humans

    It is well known that development of prostate cancer (PC) can be attributed to somatic mutations of the genome, acquired within proto-oncogenes or tumor-suppressor genes. What is less well understood is how ge...

    Jean M. Winter, Natasha L. Curry, Derek M. Gildea, Kendra A. Williams in BMC Genomics (2018)